RNA Analysis / Transcriptomics

World Market Report

MCP15286

EXECUTIVE ENGAGEMENTS

POOL

2833
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

512
Interactions with Platform & by Email

PARTICIPANTS

83
Unique # Participated

VALIDATIONS

24
Responses Validated*

COMPANIES

115
Responses Validated*
* Login for a full stack data experience

DATE

MAR 2022

TABLES

150

PAGES

504

EDITION

9

PRICE

USD 4950

CODE

MCP15286


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

STRONG ACTIVE NICHE TRIVIAL

%

VALIDATED RESEARCH *

S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year


Global RNA Analysis / Transcriptomics Market to Reach $10.5 Billion by 2026

Amid the COVID-19 crisis, the global market for RNA Analysis / Transcriptomics estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$10.5 Billion by 2026, growing at a CAGR of 14.1% over the analysis period. Reagents / Consumables, one of the segments analyzed in the report, is projected to grow at a 15.4% CAGR, while growth in the Instruments segment is readjusted to a revised 12.5% CAGR. The market is expected to register strong growth, driven by factors such as growing spend on R&D of transcriptomic technologies, and increasing use of personalized medicine in the treatment of cancer. The global market for transcriptomics technologies is projected to experience significant growth throughout the analysis period, driven by the increasing implementation of transcriptomic technologies. The gene expression patterns` increased demand for specific genes, various assay technologies, quantification of multiplexed RNA, increased requirement for genetic testing and personalized medicine, rise in genetic variation and genetic mutation incidences boost the transcriptomics technologies market demand. Additionally, continuous technological developments in products increased commercialization, and increasing disease cases such as hepatitis B, diabetes, and cancer, too, propel the transcriptomics technologies market growth. The transcriptomics extensive application in analyzing gene expression, the launch of effective and robust methodologies, increasing private and government research funding, enhanced methods of various transcriptome assessments are anticipated to augment the transcriptomic technologies growth. Pharmaceutical and biotechnology companies` R&D funding, increased demand for compact and reliable products, too, are a few factors anticipated to drive the transcriptomics technologies market growth. Sequencing platforms` high maintenance costs and increased requirement of highly efficient methodologies are the transcriptomics technologies market challenges.

The sustained increase in research and development initiatives the world over are driving the demand for reliable and sophisticated software for managing the massive quantities of research data from research and academic, and corporate institutes. New advancements in the transcriptomics field including extensive usage of RNA sequencing and growth of transcriptomics applications that include drug discovery drive the transcriptomics industry. Growth in funding and grants by government and private organizations are driving the market further. The demand is propelling life science and software companies to increasingly focus on developing state-of-the-art bioinformatics solutions and services, a trend that is powering the market`s growth. The growth within the worldwide market for transcriptomics technologies is also expected to be propelled by the sustained increase in the use of technologically advanced transcriptomics techniques, including the extensive utilization of RNA-sequencing (RNA-seq) and increase in the application areas of transcriptomics technologies, including drug discovery. The increase in grants and funding by various government and private organizations is another factor fueling growth within the market. During the forecast period, the global transcriptomics market is expected to be driven by factors such as advancements in healthcare infrastructure and growing demand for personalized medicines. Increase in the number of biopharmaceutical companies and growing expenditure in R&D are expected to boost the market growth further. Some of the key market insights are the latest advancements in transcriptomics based on technology, introduction of new products and recent industrial developments such as mergers, partnerships and acquisitions.

The increased demand for efficient treatment and diagnosis in the areas of oncology, HIV and Alzheimer`s disease leads to the development of the market, which is witnessing growth with the increasing research and development programs in the biotechnology field. Various other factors including rising government support, rising genome mapping programs, increased application areas of the technology offer a good platform. Nevertheless, data complexity, in the post transcript analysis, in the sequencing platforms is a concern and is a potential threat to the industry. Additionally, spurred by the emerging need for personalized medicines, the pharmaceutical manufacturers are increasingly focusing on developing personalized and targeted therapeutics, which is spurring the need for identifying disease-specific biomarkers. The trend is projected to significantly boost the market`s growth throughout the analysis period. Furthermore, the proliferation of biopharmaceutical companies, and increasing investments in research and development initiatives, together with sustained improvements in medical infrastructure are also contributing significantly to the growth within the worldwide market for transcriptomics technologies. Global healthcare spending increases significantly with the growing population, increased treatment access and ongoing advancements in terms of technology. It provides support for market growth in the long and medium-term future. Innovations and new product launches are also projected to fuel the growth within the worldwide market for transcriptomics technologies over the analysis period.

The design and introduction of new products are likely to fuel gains in the market, as they would enable CROs to improve research quality and help in the development of vaccination. In 2021, Rebus Biosystems introduced the Rebus Esper, a spatial transcriptomics evaluation solution. This platform leverages a laser-driven optic for images of high resolution and enables the analysis of individual cells. NuGEN Technologies, Inc.`s Trio RNA-Seq, which provides a highly sensitive end-to-end transcriptomics solution, is ideal for use in low abundance transcripts applications. The innovative Trio RNA-Seq technique integrates three powerful technologies, including single primer isothermal amplification (SPIA); AnyDeplete, for use in high sensitivity ribonucleic acid (RNA) analysis; and DimerFree. Additionally, Caris Life Sciences` MI Transcriptome, a state-of-the-art gene profiling solution, is also projected to spur growth within the worldwide market for transcriptomics technologies. The innovative MI Transcriptome, which enables WTS, holds the potential for providing a comprehensive RNA-seq analysis. Likewise, Lexogen`s CORALL-Total RNA-Seq Library Prep Kit, an innovative transcriptome analysis product, also holds the potential for revolutionizing the transcriptomics market and propelling its growth over the analysis period. Lexogen is a transcriptomics technology provider dedicated to developing innovative software and kits for RNA-Seq.

COVID-19 has boded well for the companies in the market. In 2020, NanoString Technologies, Inc. introduced the nCounter Host Response Gene Expression Panel for analysis of immune system reaction during the Coronavirus research. The solution in addition to GeoMx Digital Spatial Profiler supported researchers in understanding the manner in which COVID-19 has not affected olfactory sensory neurons. In 2021, Qiagen unveiled QIAseq DIRECT SARS-CoV-2 Kit, genome enrichment platform, and viral library preparation to lower the use of plastics and library turnover periods in comparison to sequencing that is primer-based. This product was introduced for meeting the growing need for high throughput screening to perform research of new and more dangerous SARS-CoV-2 variants. In 2021, Bio-Rad Laboratories Inc. introduced SEQuoiaRiboDepletion Kit`s latest version for NGS that enhances efficiency of assessment by eliminating unnecessary rRNA fragments from the RNA sequencing library.

In 2020, infectious diseases and pathogenesis gained a considerable market share trailed by alternative RNA splicing applications. scRNA-sequencing is gaining increasing use to attain an understanding of cell kinds vulnerable to infection. RNA structure and molecular dynamics are anticipated to register strong growth, as RNA is gaining increasing importance in new drug development. Molecular dynamics will be used to support experimental evaluation of RNA structural dynamics. Academic centres and government institutes drive market gains, given their growing use of high throughput technologies for effective RNA analysis. Transcriptomics technologies are also finding rising use in drug discovery. The market is also gaining from the rising research in drug discovery. In 2021, a drug discovery platform based on RNA sequencing has been developed known as TORNADO-seq for monitoring large gene expression for an in-depth analysis of cellular phenotypes in organoids. However, lack of professionals restrain the growth of the industry. High service cost, because of high input cost and lack of skilled workforce in the developing countries, are expected to impede the implementation of transcriptomics technologies by the end-users. Additionally, certain limitations of RNA-seq are also projected to hamper market growth.

SELECT PLAYERS

Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; CD Genomics; F. Hoffmann-La Roche Ltd.; GenXPro GmbH; Illumina, Inc.; LC Sciences; Merck KGaA; Qiagen N.V.; Sequentia Biotech SL; Thermo Fisher Scientific Inc.; Waters Corporation

SEGMENTS

» Product (Reagents / Consumables, Instruments, Services, Software) » Technology (Polymerase Chain Reaction, Sequencing, Microarray, RNA Interference) » Application (Drug Discovery, Toxicogenomics, Clinical Diagnostics, Comparative Transcriptomics)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed?
Pandemic Impact on RNA Analysis/Transcriptomics Market
RNA-Oriented Projects Set to Increase
Competition
RNA Analysis / Transcriptomics – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for 44 Players Worldwide in 2022 (E)
What is RNA-Seq Technology?
A Prelude to Transcriptomics Technologies
Global Market Prospects & Outlook
PCR Emerges as the Leading Technology
Drug Discovery Segment Poised to Lead the Global Market
North America Emerges as the Major Regional Market
World Brands
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Trend Towards Personalized Medicine Fuels Market Growth
EXHIBIT: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
EXHIBIT: World Personalized Medicine Market by Region/Country (2021)
EXHIBIT: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
EXHIBIT: Number of Available Personalized Medicines in the US (2010-2020)
EXHIBIT: Personalized Medicines as % of New FDA Drug Approvals for 2015-2020
Transcriptomics Assume Critical Importance amid Growing Prevalence of Chronic Diseases
EXHIBIT: World Diabetes and Population Statistics (2021, 2030 & 2045)
EXHIBIT: World Diabetes Prevalence (2000-2045)
EXHIBIT: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
EXHIBIT: Global HIV Prevalence: Number of People Living with AIDs (in Million) by Region as of June 2021
EXHIBIT: Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
Transcriptomics Applications in Disease and Diagnostic Profiling
Increasing PCR Applications in Biotechnology Sector
Progressive Growth of Omics Technologies: Opportunity for RNA Analysis/Transcriptomics Market
The Growing Role of Transcriptomics in Oncology
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
EXHIBIT: Number of New Cancer Cases and Deaths (in Million) by Region for 2020
RNA Sequencing Critical for Cancer and Rare Diseases
Bulk-Tissue RNA Sequencing and Single-Cell RNA Sequencing for Cardiovascular Research
Bulk RNA Sequencing
Single-Cell Sequencing
Spatial Transcriptomics
Single-Cell RNA-seq Technologies Witness Steady Growth
The Evolution of scRNA-seq
Growth of Long-Read Transcriptome Sequencing
scRNA-seq for Autoimmune Inflammatory Rheumatic Diseases
SPLiTseq Beneficial for Understanding Cause of Disease
Gene Expression Microarray Technology Gains Ground
Microfluidics-based Droplet Technologies Demonstrate Growth
inDrops Approach Exhibits Growth
Spatial Transcriptomics Market Witnesses Significant Growth
Spatial Transcriptomic Data Analysis
Next Generation Sequencing Offers Increased Accuracy for Transcriptomics Activity
Single-cell NGS Witnesses Rapid Growth
RNA Sequencing Benefits Fuel Market Prospects
Blood Transcriptome Sequencing for Identifying Rare-Disease Genes
Rising Focus on Toxicogenomics: Potential for RNA Analysis/Transcriptomics Markets
Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities
EXHIBIT: Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
EXHIBIT: R&D Spending as % of Revenues in Select Leading Pharmaceutical Companies (2020)
EXHIBIT: R&D Spending (in US$ Billion) of Select Leading Biotechnology Companies for 2020
Technological Advancements & Innovations Fuel Market Growth
Sci-Plex – A New Technique to Profile Gene Expression within Single Cells
Introduction of Oxford Nanopore’s Innovative Portable Sequencer for Sequencing Long Reads and RNA Molecules Improves Transcriptomic Analysis
RNA-Combine, a Toolkit for More Comprehensively Analyzing Transcriptome Data
Aging Demographics Present Opportunities for Transcriptomics Technologies
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
EXHIBIT: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Challenges Facing RNA/Transcriptomics Market
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for RNA Analysis / Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for RNA Analysis / Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Reagents / Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Reagents / Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Reagents / Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for RNA Interference by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for RNA Interference by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for RNA Interference by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Toxicogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Toxicogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Toxicogenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
World Recent Past, Current & Future Analysis for Comparative Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Comparative Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
World 12-Year Perspective for Comparative Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
UNITED STATES
RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
USA 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
USA 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
USA 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Canada 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Canada 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Canada 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
JAPAN
Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Japan 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Japan 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Japan 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
CHINA
RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
China 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
China 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
China 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
EUROPE
RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for RNA Analysis / Transcriptomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Europe 12-Year Perspective for RNA Analysis / Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2021 & 2027
Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Europe 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Europe 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Europe 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
FRANCE
France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
France 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
France 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
France 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
GERMANY
Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Germany 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Germany 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Germany 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Italy 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Italy 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Italy 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
UNITED KINGDOM
UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
UK 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
UK 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
UK 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Europe 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Europe 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of Europe 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
ASIA-PACIFIC
RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Asia-Pacific 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Asia-Pacific 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Asia-Pacific 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of World 12-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of World 12-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Rest of World 12-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2021 & 2027
Total Companies Profiled: 115

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com